ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 204

Ultrasonographic Predictors for Clinical and Radiological Progression in Knee Osteoarthritis after 2 Years Follow up

Karen Bevers1, Johanna E. Vriezekolk2, J.W.J. Bijlsma3, Els van den Ende4 and Alfons A. den Broeder2, 1Rheumatology, St Maartenskliniek, Nijmegen, Netherlands, 2Rheumatology, Sint Maartenskliniek, Nijmegen, Netherlands, 3Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht, Netherlands, 4Department of Rheumatology, Sint Maartenskliniek, Nijmegen, Netherlands

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Knee, osteoarthritis and ultrasonography

  • Tweet
  • Email
  • Print
Session Information

Title: Osteoarthritis - Clinical Aspects: Imaging and Biomechanics

Session Type: Abstract Submissions (ACR)

Background/Purpose

Pathophysiology of osteoarthritis (OA) is not completely understood. Identifying patients with progression might help to direct future research on therapeutic interventions. As OA is known to affect the entire joint including soft tissue structures, structural changes in these tissues, visualised by ultrasound (US),  might predict progression. The aim of this study was to investigate the association between a set of US features and radiographic and clinical progression of knee OA after two years of follow up.

Methods

A total of 125 patients  fulfilling American College of Rheumatology clinical criteria for knee OA1 underwent US examination of the most symptomatic knee. The US protocol included assessment of synovial hypertrophy, joint effusion, infrapatellar bursitis,  Baker’s cyst, medial meniscus protrusion and cartilage thickness. Clinical progression was defined using  the inverse OARSI responder criteria 2or progression to total knee replacement. A 2-point or more increase in Altman score or progression to total knee replacement was considered radiologic progression. Regression analyses were performed with US features as independent variables and progression (two separate models for clinical progression and radiographic progression) as dependent variable. 

Results

A total of 31 (25%) patients fulfilled the criteria of clinical progression and 60 (48%) patients fulfilled the criteria of radiologic progression. Presence of Baker’s cyst showed a statistically significant association with clinical (OR: 3.07; 95% CI: 1.21 – 7.78) as well as radiological (OR: 2.84; 95% CI: 1.17 – 6.90) progression. Synovial hypertrophy showed a weaker but consistent association with clinical- as well as radiologic progression (OR: 2.11; 95% CI: 0.80 – 5.57)

Conclusion

We demonstrated a longitudinal association between Baker’s cyst (and to a lesser extent synovial hypertrophy) at baseline and radiological and clinical progression after two years. When confirmed, these inflammatory variables might be candidate features to help define knee OA patients with worse prognosis.

Reference List

  (1)   Altman R, Asch E, Bloch D et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 1986;29(8):1039-1049.

  (2)   Pham T, van der Heijde D, Altman RD et al. OMERACT-OARSI initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited. Osteoarthritis Cartilage 2004;12(5):389-399.


Disclosure:

K. Bevers,
None;

J. E. Vriezekolk,
None;

J. W. J. Bijlsma,
None;

E. van den Ende,
None;

A. A. den Broeder,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/ultrasonographic-predictors-for-clinical-and-radiological-progression-in-knee-osteoarthritis-after-2-years-follow-up/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology